Data From Three Phase II Clinical Trials of PS-Targeting Antibody to Be Presented at 2010 ASCO Annual Meeting

After losing his rights, songwriter fights back
A court stripped away songwriter Danny Tate’s control of his life — removing his right to make his own legal, financial and medical decisions — at a last-minute hearing he didn’t know about and didn’t attend.

Read more on AP via Yahoo! News

4-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24 …
McCAFFREY ALSO TUES., MAY 25 NOON–RIBBON CUTTING -OPENING NEW CANYON PARK TREATMENT SOLUTIONS, 22026 20(TH) AVE. SE, BOTHELL

Read more on redOrbit

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.

Read more on News-Medical-Net

Related Drug Addiction Blogs

• Penny Stocks Alert | ytlsf blog
• How New Oval Stem Cell Marker Antibodies Will Benefit Hepatic …
• Preclinical Development Of Monoclonal Antibodies And Related …
• Guest Post: Old myths about Vietnam resurface « BurnPit
• The Liberty Papers »Blog Archive » Nation's Drug Czar Laments Drug …
• Rights lost to conservator, songwriter fights back | Palm Beach …
• A short video message to Danny Tate supporters about the Awareness …
• The Associated Press has picked up on the Danny Tate story …
• Danny Tate pays it forward to another Nashville flood victim …
• Former White House Drug Czar Barry McCaffrey Lays Out Case Against …